About: Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.94 (+4.34%)
CNTB NASDAQ Connect Biopharma Holdings Ltd
Loading watchlist status…
Connect Biopharma Holdings Ltd share price
CNTB price activity
Last Price
$0.940
Change (24hr)
0.04 USD (4.34%)
Volume
1.22M
Volume (4w avg)
-
Open
$0.90
Day Range
$0.89 - $0.97
Previous Close
$0.91
Last Trade
07 Oct, 8:27 pm GMT+0
Delayed
07 Oct, 8:27 pm GMT+0
CNTB price performance
-3.57%
5D
-48.66%
1M
-66.5%
YTD
-46.93%
1Y
Delayed
07 Oct, 8:27 pm GMT+0
CNTB Market Signals